Neuro-oncology pediatrics

The DIPG/DMG National Tumor Board: The power of advocacy.

Pub Date : 2026-10-01 DOI: 10.1093/neuped/wuaf009 Rebecca Ronsley, Greta Peng, Eileen Gutierrez, Patricia Baxter, Jason Fangusaro, Adam L Green, Lindsay B Kilburn, Carl Koschmann, Jasia Mahdi, Michelle Monje, Ashley S Plant-Fox, Nicholas A Vitanza, Sebastian M Waszak, Cheng-Chia Fred Wu, Matthew J Barkovich, David Mirsky, Sabine Mueller

FOXR2-activated CNS neuroblastoma: Characterized by variable structural disruption of the FOXR2 regulatory region, recurrent copy number alterations, and elevated FOXR2 expression.

Pub Date : 2026-03-19 DOI: 10.1093/neuped/wuag014 Jianling Ji, Venkata Yellapantula, Dong Xu, Dolores Estrine, Alexander Markowitz, Jennifer Han, Katherine Ma, Cindy Fong, Debra Hawes, Ashley Margol, Katrina O'Halloran, Nathan J Robison, Jaclyn A Biegel, Jennifer A Cotter, Gordana Raca, Jessica W Tsai

Alternative splicing in pediatric central nervous system tumors highlights oncofetal candidate CLK1 exon 4.

Pub Date : 2026-02-16 DOI: 10.1093/neuped/wuag009 Ammar S Naqvi, Patricia J Sullivan, Ryan J Corbett, Priyanka Sehgal, Karina L Conkrite, Komal S Rathi, Brian M Ennis, Katharina E Hayer, Bo Zhang, Miguel A Brown, Daniel P Miller, Alex Sickler, Adam A Kraya, Kaleem L Coleman, Joseph M Dybas, Zhuangzhuang Geng, Christopher Blackden, Shehbeel Arif, Antonia Chroni, Aditya Lahiri, Madison L Hollawell, Phillip B Storm, Dalia Haydar, Jessica B Foster, Mateusz Koptyra, Peter J Madsen, Sharon J Diskin, Andrei Thomas-Tikhonenko, Adam C Resnick, Jo Lynne Rokita